Financials
Financial year 2025
ITIPHARMA GHYSELEN from Soignies, company number BE1028767449, closed financial year 2025 with a result of € 33,287 after tax. For that financial year ITIPHARMA GHYSELEN recorded a gross margin of € 41,898 and equity of € 36,287. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 36,287
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 33,287
Profit after tax over the fiscal year.
€ 47,464
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 33,287.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 1,428
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,478
Supplier invoices still open on the last day of the fiscal year.
€ 24,151
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to ITIPHARMA GHYSELEN?
What happened at ITIPHARMA GHYSELEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 33,287. Source: NBB ↗
- New establishment in Soignies. KBO
- Geoffrey Ghyselen became a director. NBB
- Start of the company according to the CBE. KBO
In short
Paid € 8,440 in corporate taxes since 2025.
A new publication or filing at ITIPHARMA GHYSELEN? We notify you, reason included.
Follow ITIPHARMA GHYSELENDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind ITIPHARMA GHYSELEN is Geoffrey Ghyselen.
Directors
According to the 2025 annual accounts
Geoffrey Ghyselen
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Clos Remy Van den Abeele 9 box 3/1
7060 Soignies
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1028.767.449
- VAT number
- BE 1028.767.449
- Registered office
- Clos Remy Van den Abeele 9 bus 3/1, 7060 Soignies
- Names & denominations
- ITIPHARMA GHYSELEN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 October 2025
- Peppol
- Active · Active since 11 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Overige zakelijke dienstverlening, neg